| Mr Mohammad Hammad, | |
|
10600 W Layton Ave, Greenfield, WI 53228-3258 | |
| (479) 321-2175 | |
| Not Available |
| Full Name | Mr Mohammad Hammad |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 10600 W Layton Ave, Greenfield, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134728009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14819-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mohammad Hammad, 10600 W Layton Ave, Greenfield, WI 53228-3258 Ph: (479) 321-2175 | Mr Mohammad Hammad, 10600 W Layton Ave, Greenfield, WI 53228-3258 Ph: (479) 321-2175 |
News Archive
Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology company, and subsidiary of Emmaus Life Sciences, Inc., today announced that the European Commission (EC) has granted Orphan Medicinal Product designation for the company's investigational drug Levoglutamide (L-glutamine) for the treatment of sickle cell disease.
New This Week In The Kaiser Global Health Policy Tracker: The President's Malaria Initiative announced a new focus country and USAID released a new fact sheet on the agency's reform initiative. Kaiser's Policy Tracker provides a timely single reference point for the latest information on congressional and administration action on global health.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Gulf Coast Medical Center has selected its ProVation® MD software for gastroenterology procedure documentation and coding.
A study by the Barcelona Public Health Agency has revealed those sections of the population that are most vulnerable to tuberculosis. The research, published in the journal Respiratory Research, shows that the highest death rates from this disease are among those aged over 50 or infected with HIV.
Advanced Cell Technology, Inc. or "ACT" reported that a range of therapeutic cell types obtained from induced pluripotent stem (iPS) cells exhibit abnormal expansion and early cellular aging. The research, which appears online (published-ahead-of- print) in the journal STEM CELLS by ACT and its collaborators at Stem International (SCRMI), Harvard Medical School, and the University of Illinois, compares a variety of replacement cell types derived from human iPS cells with their embryonic stem (ES) cell counterparts. The findings support the use of ACT's single blastomere-derived human embryonic stem cell lines which do not display early aging.
› Verified 8 days ago
Samantha Hilt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Sura Ln, Greenfield, WI 53228 Phone: 414-246-6700 | |
Rick Staral, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4296 S 76th St, Greenfield, WI 53220 Phone: 414-321-7602 | |
Mark E Sharafinski Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4911 W Maple Leaf Cir, Greenfield, WI 53220 Phone: 414-335-7703 | |
Mr. Jon Jay Golembiewski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4688 S 108th St, Greenfield, WI 53228 Phone: 414-303-6237 | |
Mr. Joseph Anthony Lacroix, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4405 W Layton Ave, Greenfield, WI 53220 Phone: 414-281-5762 | |
Jaclyn Aremka, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4777 S 27th St, Greenfield, WI 53221 Phone: 414-282-0634 |